Months after landing Canadian site from government, Resilience announces a big mRNA partner
Bob Nelsen’s latest project, dreamed up out of anger, has been focused on becoming the Amazon Web Services of drug manufacturing, with the ability to scale in the most efficient way possible. It has now partnered with one of the most influential players in the pandemic response.
Resilience will start making mRNA for Moderna’s Covid-19 vaccine at its new site in Canada, the company announced Wednesday.
The company had already struck a deal with the Canadian government to capitalize off of $163 million in spending from Prime Minister Justin Trudeau’s administration to expand mRNA production capacity. The money will go toward a new manufacturing site in Mississauga, east of Toronto, which will have the capacity to make between 112 million and 640 million mRNA vaccine doses a year.
“Moderna’s Covid-19 vaccine has saved countless lives, and we’re excited to manufacture mRNA for this important vaccine,” CEO Rahul Singhvi said in a press release. “This collaboration has the potential to ensure more people are protected around the world from the deadly Covid-19 virus.”
Resilience was founded in 2020, and focuses on end-to-end manufacturing that can free up time for its partners to work on perfecting the drugs. The company emerged from stealth in November with $800 million in funding from Nelsen’s Arch Venture Partners. Nelsen started the company because he was frustrated with how long it was taking to get things off the ground in the response to the pandemic.
The company hasn’t been sitting on the sidelines. Since its inception, it has kicked up a flurry of acquisitions, shelling out $110 million for bluebird bio’s North Carolina lentiviral vector manufacturing facility just two years after the company bought the site and spent another $80 million on it in upgrades. It took on a 310,000 square-foot plant in Boston from Sanofi and another 136,000 square-foot site in Ontario to add up its network in March, just three months after the company emerged.